Introduction
Blood pressure (BP) measured at home by patients (home BP) has become increasingly popular in the diagnosis of arterial hypertension and in the assessment of the response to antihypertensive therapy. [1] [2] [3] Compared to BP measured by a doctor in his surgery (office BP), home BP can provide a greater number of readings leading to improved accuracy. It obviates the 'white coat effect', and if an automated device is used prevents observer bias. [2] [3] [4] In hypertensive patients, home BP has been consistently reported to be lower than office BP, [4] [5] [6] [7] [8] [9] [10] [11] [12] but whether home BP could replace ambulatory recorded BP in the management of hypertension in general practice is uncertain. 13 Few studies have examined the relationship between office BP and home BP in the course of an antihypertensive treatment in patients followed by their general practitioner. 8, 14 The aim of the present study was to compare office BP and home BP in hypertensive patients before and during antihyper-tensive therapy. The evolution of home BP measured twice daily during a 1-week period was also examined. Sustained-release diltiazem was chosen as treatment because it is an effective and welltolerated antihypertensive agent.
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Methods
Subjects
Male and female patients aged between 18 and 75 years were included if their diastolic office BP was between 95 and 110 mm Hg and systolic office BP below 180 mm Hg during two consecutive visits within a 1-week period. Previously treated hypertensive patients underwent a 2-week wash-out period prior to participation. Patients with coronary artery disease, stroke or any other chronic serious illness, and those needing an antihypertensive drug other than diltiazem were excluded from the study.
Study design
The protocol of this open prospective study was approved by the Ethics Committee of the Erasme University Hospital and written informed consent was obtained from each patient. Between the two screening visits without antihypertensive treatment, patients measured their home BP and heart rate at home during 8 consecutive days. If inclusion criteria were met patients received sustained-release diltiazem 300 mg, once daily in the morning, for 2 months. Visits to the general practitioner were planned after 4 and 8 weeks of therapy. Patients again measured their home BP for the 8 consecutive days before the last visit.
Measurements
Office measurements: During each visit, the general practitioner performed three measurements of sitting heart rate and BP after 5 min of rest using a mercury or an aneroid manometer with a cuff of appropriate size placed on the non-dominant arm. Korotkoff phase 1 and phase 5 were used for systolic and diastolic BP determinations respectively. The mean of the three recordings was taken as the office measurement.
Home measurements: Sitting heart rate and BP were recorded at home by the patient using a validated fully automated oscillometric device equipped with a printer (OMRON-HEM 705 CP, OMRON Corp, Tokyo, Japan). 16 The use of the device was briefly explained and demonstrated to the patient by the general practitioner. The patients were asked to measure their BP on the nondominant arm, twice daily, in the morning between 6.30 and 8.30 am and in the evening between 6.30 and 8.30 pm, during two 8-day periods before and after the 8-week treatment period. A cuff of appropriate size was provided. Patients stuck the printed values of heart rate, BP, date and time in a diary, which guaranteed the reliability of the reported values. 17, 18 The mean of all available values from each 8-day period defined the home BP.
Analysis of the data
Data from patients who provided at least one printout of home BP were included in the analysis. Data are presented as means ± one standard deviation. Paired t-tests were used to compare heart rate and BP before and after treatment. Pearson correlation coefficients were calculated to examine the relation between office and home BP. Slope and intercept of the regression line were compared to the identity line using Fisher's test. Agreement between these two methods was also analysed according to the method of Bland and Altman. 19, 20 Calculations were performed with the SAS statistical package version 6.12.
Results
The demographics of the 760 patients included are presented in Table 1 . The majority of the patients (n = 626) completed the study. Drop-outs were due to adverse events (n = 58); unwillingness to continue in the study (n = 24); insufficient antihypertensive effect of the treatment as estimated by the general practitioner (n = 14); loss of follow-up (n = 5); and other reasons (n = 33). Most of the patients (n = 632) performed at least one home BP. The mean number of home BP measurements was 29 ± 9 which is close to the expected number of 32. However the range was large, from 1 to 101. The mean number of days with home BP measurements was 16 ± 5 (range 1-66).
Effects of diltiazem
Diltiazem significantly reduced systolic and diastolic office BP and home BP as well as heart rate ( Table 2 , P Ͻ 0.001). Of the 457 patients who had at least one home BP recording before and during treatment, BP was reduced to normal in 94 patients according to office BP (Ͻ140 and 90 mm Hg) 1, 2 ; in 25 patients according to home BP (Ͻ135 and 85 mm Hg) 4 and in 57 patients according to both methods.
Office and home BP recordings
Both before and during antihypertensive treatment a terminal digit preference for 0 and 5 was observed in office BP measurements but not in home BP measurements (data not shown). Before antihypertensive treatment, mean home BP was lower than office BP (Table 2) . During treatment, diastolic home BP was slightly higher than diastolic office BP whereas systolic home BP and office BP were not significantly different. Home and office heart rate were similar both before and during treatment.
Among 457 patients, 12 had office hypertension (Ͼ140 and 90 mm Hg) 1,2 but a normal home BP (Ͻ135 and 85 mm Hg) 4 before, and 25 during, treatment. The relationship between office BP and home BP was analysed in the 457 patients who had at least one home BP measurement before and during treatment. The slope and intercept of the regression line, obtained by plotting home BP against office BP, was compared with the slope of the identity line. Slopes were significantly different from 1 (ie, the slope of the identity line) (P Ͻ 0.01) and intercepts were significantly different from zero (ie, the intercept of the identity line) (P Ͻ 0.01), for systolic and diastolic BP, both before and during treatment ( Table 3) .
The correlation coefficient was calculated between the office-home BP difference and their average (Figure 1) . 19 This coefficient is zero if the variances are equal. 19 Coefficients were −0.2 (systolic BP before treatment), −0.47 (diastolic BP before treatment, Figure 1 ), −0.14 (systolic BP during treatment), and −0.13 (diastolic BP after treatment), and all were significantly different from zero (P Ͻ 0.005). 19 Thus, home BP was higher than office BP in the highest range of BP, whereas it was lower than office BP in the lowest range. 
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Evolution in home BP over time
The evolution of home BP during 8 consecutive days is shown in Figure 2 . Systolic home BP was higher in the evening than in the morning before treatment (by 4.1 ± 9.5 mm Hg over the 8 days, P Ͻ 0.001) and during treatment (by 2.5 ± 9.3 mm Hg, P Ͻ 0.001). The difference in diastolic home BP between the evening and the morning was 0.7 ± 7.1 mm Hg (P = 0.05) before treatment and −0.4 ± 6.4 mm Hg (not significant) during treatment.
Systolic and diastolic home BP before treatment significantly decreased from the first to the second day (by 3.3 ± 14 mm Hg, P Ͻ 0.001 and by 1.7 ± 11.2 mm Hg, P Ͻ 0.01, respectively) and remained stable thereafter. During treatment there was no significant difference in systolic and diastolic home BP between the first and eighth day of measurements.
Discussion
Sustained-release diltiazem reduced home and office BP and heart rate. Average home BP was lower than average office BP before, but not during, antihypertensive treatment. Steady values of home BP were obtained after the second day of measurements. The main finding of this study is that the difference between home BP and office BP was not constant throughout the range of BP, home BP being higher than office BP for high values and lower for low values.
In untreated hypertensive patients average home BP was lower than office BP as previously reported, [4] [5] [6] [7] [8] [9] [10] [11] [12] while during treatment such difference between both methods was no longer observed. 11, 14 In a substudy of the Hypertension Optimal Treatment trial, after the titration of treatment in 926 patients, the differences between office BP and home BP of 0.5 mm Hg for systolic BP and of 0.2 mm Hg for diastolic BP were not significant. 14 The smaller office-home BP difference during treatment could be due to the lower BP levels obtained with antihypertensive therapy. It could also be due to an attenuation of the white-coat effect over time. In the SAMPLE study the office-home BP difference decreased with antihypertensive therapy and only partially returned toward the pretreatment values after a final placebo period. 11 However, in the present study more patients had normal home BP and office hypertension before than during antihypertensive treatment.
Home BP and office BP did not agree throughout the range of BP measurement: home BP was higher than office BP in the highest range of BP whereas it was lower than office BP in the lowest range ( Figure  1 ). Interestingly Chatellier et al 8 observed a similar, but even more pronounced, pattern particularly for diastolic BP. In most studies the difference between office BP and home BP was roughly proportional to the value of the office BP although office BP was always higher than home BP. 3, 5, 9 In the present study, the higher home BP could in part be explained by a slight overestimation of systolic BP by the OMRON device in the high-pressure range. 16 Another explanation for the poor agreement could be that whereas the timing of home BP measurement was standardised in the morning and in the evening, timing was not standardised for office BP measurements which occurred randomly throughout the day. In addition, different devices were used for home and office measurements. An office BP reading by the general practitioner using the home BP device was not performed in the present study. It could also be hypothetised that some physicians want to see lower BP values after initiation of therapy and systematically report values to the nearest lower 5 mm Hg. This could explain why office BP was lower than home BP in the high range during treatment but does not explain the same trend before antihypertensive therapy.
Before antihypertensive treatment, home BP decreased from the first to the second day of measurements for systolic and diastolic BP, and they remained stable thereafter. These results are close to those of Stergiou et al 6 who showed that averaging home BP measurements from the second and third days provides a reliable estimate of home BP, and to those of Celis et al 7 who showed that 3 days of home measurements were sufficient to obtain steady values of home BP in elderly subjects. During treatment systolic and diastolic BP were comparable during the 8-day period of home BP measurements.
In conclusion, this study shows that the difference between home BP and office BP is not constant throughout the range of BP, so that home BP can be higher than office BP. This finding suggests that great care must be taken in the interpretation of home BP readings for the diagnosis of arterial hypertension and the monitoring of its treatment.
